Decentralization in clinical trials is quickly turning into a must-have for companies that truly want to support patients, provide more convenience and reach recruitment goals. Decentralized clinical trials (DCTs) hold the potential to reach new, remote patient populations, innovate rare and orphan disease research, and accelerate medical discovery. In order …
Decentralized Clinical Trial Regulations: A 2022 Report Read More »
The Covid-19 pandemic that began in 2020 had a devastating effect on our health as well as the global economy. The impact on the clinical research industry, in particular, is complex. On the one hand, the development of new vaccines and treatments gave a huge boost to research in two …
Recovering from Covid: The 2021 Clinical Research Market Read More »
Are you planning a fully virtual or a hybrid clinical trial? Then you need The Ultimate Guide to Virtual Clinical Trial Vendors. Covid-19 and the global lockdowns that followed made digital transformation a top priority in the clinical research world. The need to support patients and operations remotely was at …
The Ultimate Guide to Virtual Clinical Trial Vendors Read More »
“85% of clinical trials fail to recruit and retain enough patients in order to meet their enrollment timeline” – a number which we see quite often in analyses, publications, or events presentations within the clinical research industry. With one-third of study budgets going into patient recruitment and hundreds of experienced …
What is the patient journey of people actively looking for clinical trials? Read More »
The last few months have been undoubtedly a challenge for the whole society and have left a significant mark in history. Although many industries have been impacted by the Covid-19 pandemic, one of the most impacted sectors has been healthcare. The coronavirus crisis has brought out many lessons with itself …
How Covid-19 impacted patient communities worldwide? Read More »
At the beginning of this global lockdown, my colleagues and I had some assumptions, concerns and predictions about the impact of Covid-19 on clinical trials and more specifically – patient enrollment. We anticipated a lot of worried patients who, themselves belonging to various risk groups, would be anxious to make …
Why High-Risk Patients Are Still Willing to Visit a Site Weekly? Read More »
2020 began with a surprise for many people, industries and governments. The coronavirus outbreak turned the world upside down and became a global threat the likes of which we hadn’t experienced for ages. Unfortunately, the clinical research industry was also impacted severely mostly due to the social distancing measures recommended …
Guidance on the Management of Clinical Trials during COVID-19: How Countries respond Read More »
We help CROs and sponsors to stop fixing patient recruitment challenges and start preventing them.
